Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast CancerAude-Hélène Capietto(Inserm), Jean‐Jacques Fournié(Inserm)The Journal of ImmunologyJune 14, 201110.4049/jimmunol.1100681Cited by 108SaveCiteExport RISWatch citationsRelated PapersBromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies|Blood|2009|140